Tarek Assi

1.6k total citations
85 papers, 903 citations indexed

About

Tarek Assi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Tarek Assi has authored 85 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 40 papers in Pulmonary and Respiratory Medicine and 15 papers in Surgery. Recurrent topics in Tarek Assi's work include Sarcoma Diagnosis and Treatment (13 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Renal cell carcinoma treatment (6 papers). Tarek Assi is often cited by papers focused on Sarcoma Diagnosis and Treatment (13 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Renal cell carcinoma treatment (6 papers). Tarek Assi collaborates with scholars based in Lebanon, France and United States. Tarek Assi's co-authors include Elie Rassy, Joseph Kattan, Olivier Mir, Nicholas Pavlidis, Marwan Ghosn, Ziad Bakouny, Fadi El Karak, Ali N. Chamseddine, Salem Chouaı̈b and Tony Ibrahim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Cancer.

In The Last Decade

Tarek Assi

78 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tarek Assi Lebanon 17 400 334 170 125 114 85 903
Florian Kocher Austria 18 498 1.2× 357 1.1× 215 1.3× 160 1.3× 130 1.1× 72 990
Ciara M. Kelly United States 15 520 1.3× 498 1.5× 136 0.8× 129 1.0× 184 1.6× 64 1.1k
Sung Hoon Sim South Korea 18 493 1.2× 325 1.0× 243 1.4× 230 1.8× 131 1.1× 81 1.0k
Thomas J. Semrad United States 15 395 1.0× 237 0.7× 257 1.5× 162 1.3× 122 1.1× 51 890
Shinkyo Yoon South Korea 18 565 1.4× 521 1.6× 239 1.4× 151 1.2× 173 1.5× 84 1.1k
Terenig Terjanian United States 10 490 1.2× 182 0.5× 126 0.7× 134 1.1× 163 1.4× 30 935
Claudia Proto Italy 18 780 1.9× 531 1.6× 213 1.3× 150 1.2× 67 0.6× 93 1.2k
Renata Zaucha Poland 16 455 1.1× 232 0.7× 130 0.8× 85 0.7× 297 2.6× 54 1.1k
Alexander T. Falk France 18 324 0.8× 485 1.5× 151 0.9× 106 0.8× 237 2.1× 56 948

Countries citing papers authored by Tarek Assi

Since Specialization
Citations

This map shows the geographic impact of Tarek Assi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarek Assi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarek Assi more than expected).

Fields of papers citing papers by Tarek Assi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarek Assi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarek Assi. The network helps show where Tarek Assi may publish in the future.

Co-authorship network of co-authors of Tarek Assi

This figure shows the co-authorship network connecting the top 25 collaborators of Tarek Assi. A scholar is included among the top collaborators of Tarek Assi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarek Assi. Tarek Assi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Italiano, Antoine, Jakob Dupont, Tarek Assi, et al.. (2025). The correlation of liquid biopsy genomic data to radiomics in colon, pancreatic, lung and prostatic cancer patients. European Journal of Cancer. 226. 115609–115609. 1 indexed citations
2.
Assi, Tarek, Carine Ngo, Matthieu Faron, et al.. (2025). Therapeutic advances in Tenosynovial giant cell Tumor: Targeting the CSF1/CSF1R axis. Cancer Treatment Reviews. 134. 102904–102904. 1 indexed citations
3.
Ammari, Samy, A. Camez, Yasmina Chaibi, et al.. (2024). Contribution of an Artificial Intelligence Tool in the Detection of Incidental Pulmonary Embolism on Oncology Assessment Scans. Life. 14(11). 1347–1347. 2 indexed citations
4.
Beddok, Arnaud, Mickaël Tordjman, Roger Sun, et al.. (2024). Integrating Artificial Intelligence and PET Imaging for Drug Discovery: A Paradigm Shift in Immunotherapy. Pharmaceuticals. 17(2). 210–210. 8 indexed citations
5.
Baldini, Capucine, Tarek Assi, Alice Bernard‐Tessier, et al.. (2022). Radiological patterns of tumour progression in patients treated with a combination of immune checkpoint blockers and antiangiogenic drugs. European Journal of Cancer. 167. 42–53. 3 indexed citations
6.
Rassy, Elie, Stergios Boussios, Tarek Assi, et al.. (2022). Sarcoma of unknown primary: myth or reality?. Journal of the Egyptian National Cancer Institute. 34(1). 27–27. 3 indexed citations
7.
Ammari, Samy, Tarek Assi, Mehdi Touat, et al.. (2021). Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab. Diagnostics. 11(7). 1263–1263. 14 indexed citations
8.
Assi, Tarek, Joseph Kattan, Elie Rassy, et al.. (2021). Chemotherapy in the management of periosteal osteosarcoma: A narrative review. Journal of bone oncology. 30. 100389–100389. 13 indexed citations
9.
Farhat, Fadi, Bassim Al Bahrani, Eman Sbaity, et al.. (2020). Comprehensive review into the challenges of gastrointestinal tumors in the Gulf and Levant countries. World Journal of Clinical Cases. 8(3). 487–503. 5 indexed citations
10.
Rassy, Elie, Tarek Assi, & Nicholas Pavlidis. (2020). Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?. British Journal of Cancer. 122(8). 1124–1132. 33 indexed citations
11.
Assi, Tarek, Elie Rassy, Fadi Farhat, et al.. (2020). TRK inhibition in soft tissue sarcomas: A comprehensive review. Seminars in Oncology. 47(1). 73–84. 8 indexed citations
12.
Assi, Tarek, Elie Rassy, Fadi Farhat, & Joseph Kattan. (2019). Overview on the role of preoperative therapy in the management of kidney cancer. Clinical & Translational Oncology. 22(1). 11–20. 5 indexed citations
13.
Bakouny, Ziad, Tarek Assi, Elie Rassy, & Fadi Nasr. (2018). Second-line Treatments of Advanced Hepatocellular Carcinoma. Journal of Clinical Gastroenterology. 53(4). 251–261. 20 indexed citations
14.
Assi, Tarek, Joseph Kattan, Elie Rassy, et al.. (2018). Efficacy and safety of everolimus in hormone receptor positive breast cancer in a developing country: Real-life single institutional experience. Journal of Cancer Research and Therapeutics. 14(5). 1112–1116. 2 indexed citations
15.
Kattan, Joseph, Elie Rassy, Tarek Assi, Ziad Bakouny, & Nicholas Pavlidis. (2018). A comprehensive review of the role of immune checkpoint inhibitors in brain metastasis of renal cell carcinoma origin. Critical Reviews in Oncology/Hematology. 130. 60–69. 17 indexed citations
16.
Assi, Tarek, et al.. (2017). Response of an ovarian granulosa cell tumor with everolimus and exemestane after initial response to letrozole. Anti-Cancer Drugs. 28(8). 931–933. 2 indexed citations
17.
Moujaess, Elissar, May Fakhoury, Tarek Assi, et al.. (2017). The Therapeutic use of human albumin in cancer patients’ management. Critical Reviews in Oncology/Hematology. 120. 203–209. 53 indexed citations
18.
19.
Assi, Tarek, Elie Rassy, Samer Tabchi, et al.. (2015). Treatment of cancer patients in their last month of life: aimless chemotherapy. Supportive Care in Cancer. 24(4). 1603–1608. 24 indexed citations
20.
Rassy, Elie, Samer Tabchi, Fadi Haddad, et al.. (2015). Acquired factor inhibitor in a patient with monoclonal gammopathy of undetermined significance responding to rituximab. Blood Coagulation & Fibrinolysis. 27(7). 822–824.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Florian Kocher Breakdown of academic impact, for papers by Ciara M. Kelly Breakdown of academic impact, for papers by Sung Hoon Sim Breakdown of academic impact, for papers by Thomas J. Semrad Breakdown of academic impact, for papers by Shinkyo Yoon Breakdown of academic impact, for papers by Terenig Terjanian Breakdown of academic impact, for papers by Claudia Proto Breakdown of academic impact, for papers by Renata Zaucha Breakdown of academic impact, for papers by Alexander T. Falk
Rankless by CCL
2026